Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kamer, R. S.
space
  arrow  Sivak, S. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REPLY

Does Eating Garlic Lower Cholesterol?

right arrow Russell S. Kamer, MD; Stephen Warshafsky, MD; and Steven L. Sivak, MD

1 June 1994 | Volume 120 Issue 11 | Pages 969-970


IN RESPONSE:

Drs. Lerner and Hulley mention only the null studies excluded, but most of the excluded studies favored garlic. Our objective was to study the effect of garlic on hypercholesterolemic patients, and we included trials in which most patients had cholesterol levels greater than 200 mg/dL. Most studies did not enroll patients based on cholesterol levels alone but rather on the presence of coronary artery disease, diabetes, hypertension, or hyperlipidemia of varying definitions. Thus, an arbitrary percentage cutoff was necessary. One study of 33 patients [1] showing no effect of garlic was excluded, but so was another randomized, placebo-controlled study (68 patients) that showed a 23% reduction in cholesterol levels that was associated with garlic [2].

We agree that including missing data would give more precise estimates. The study with null results had a short-duration, crossover design and no washout period [3]. As Dr. Hulley has stated, the crossover design is disadvantageous because of "an added complexity of analysis and interpretation created by the elusive problem of carryover effects" [4]. Therefore, one cannot assume that garlic had no effect unless data from the first period were reported. Again, a study showing a positive effect of garlic was also excluded for failure to meet this criterion [5].

We did a sensitivity analysis on noncontrolled trials to be sure that we did not overlook studies showing no effect and to examine the magnitude and consistency of garlic's effect. The cholesterol-lowering effect of garlic in these eight studies was homogeneous and seen in the garlic-treated arms of the primary analysis. By contrast, meta-analysis showed that placebo groups had a 4% decrease in serum cholesterol levels, a better estimate of "regression to the mean" or "placebo effect".

Because the quality of the included trials and their appearance in unfamilar journals also concerned us, we did a comprehensive, critical quality assessment and reported the results in both the body of the paper and in the appendix.

Millions of people already take garlic supplements for their alleged health benefits. On the basis of our rigorous, unbiased, quantitative review of the literature, we believe that garlic does indeed lower cholesterol levels.


Author and Article Information
space
up arrowTop
dotAuthor & Article Info
down arrowReferences

New York Medical College; Valhalla, NY 10595


References
space
up arrowTop
up arrowAuthor & Article Info
dotReferences

1. Sitprija S, Plengvidhya C, Kangkaya V, Bhuvapanich S, Tunkayoon M. Garlic and diabetes mellitus phase II clinical trial. J Med Assoc Thai. 1987; 70(Suppl 2):223-7.

2. Bordia A. Effect of garlic on blood lipids in patients with coronary heart disease. Am J Clin Nutr. 1981; 34:2100-3.

3. Luley C, Lehmann-Leo W, Moller B, Martin T, Schwartzkopf W. Lack of efficacy of dried garlic in patients with hyperlipoproteinemia. Arzneimittelforschung. 1986; 36:766-8.

4. Hulley SB, Feigal D, Martin M, Cummings SR. Designing a new study: IV. Experiments. In: Hulley SB, Cummings SR, eds. Designing Clinical Research. Baltimore: Williams & Wilkins; 1988:124.

5. Kanziora J. Blutdruck and lipidsenkende wirkumg eines knoblauchpraparates in kombinatin mit einem diuretikum. Arztliche Forschung. 1988; 35:3-8.

About Letters
space

The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

•Include no more than 300 words of text, three authors, and five references

•Type with double-spacing

•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.

Annals welcomes electronically submitted letters.





box Article
 arrow  Table of Contents                
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Kamer, R. S.
space
  arrow  Sivak, S. L.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online